Recce Pharmaceuticals Ltd.

Recce Pharmaceuticals Ltd.

0.21
EUR
+0.00
(-0.93%)
-0.03EPS
70.56MMarket Cap
Mar 01Next Earn

Latest Stock Split

Apr 15, 2025

105:104

For every 104 shares held, investors received 105. The price per share adjusted from $0.14 to $0.14.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Apr 15, 2025
    Before$0.14
    Split ratio105:104
    After$0.14
    Forward
  2. Sep 13, 2023
    Before$0.36
    Split ratio405:401
    After$0.36
    Forward

About Recce Pharmaceuticals Ltd. stock splits

Recce Pharmaceuticals Ltd. (GETTEX:R9Q) operates in the Pharmaceuticals: major industry.

Recce Pharmaceuticals Ltd. company overview

When did Recce Pharmaceuticals Ltd. stock split?

Recce Pharmaceuticals Ltd.'s most recent stock split was on April 15, 2025. It was a 105-for-104 forward split, so shareholders received 105 shares for every 104 they held.

What is Recce Pharmaceuticals Ltd.'s stock split history?

Recce Pharmaceuticals Ltd. (GETTEX:R9Q) has split its stock 2 times: a 405-for-401 split on September 13, 2023 and a 105-for-104 split on April 15, 2025.

How many times has Recce Pharmaceuticals Ltd. stock split?

Recce Pharmaceuticals Ltd. has split its stock 2 times. This history records 2 forward splits between September 13, 2023 and April 15, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Recce Pharmaceuticals Ltd.'s 105-for-104 split on April 15, 2025, every 104 shares became 105 shares.

Will Recce Pharmaceuticals Ltd. split its stock again?

Recce Pharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on April 15, 2025, 1 year ago. Companies announce splits in advance, and any new GETTEX:R9Q split will appear on this page.